Suppr超能文献

糖尿病患者移动应用程序的评估:一项范围综述

Evaluation of Mobile Applications for Patients with Diabetes Mellitus: A Scoping Review.

作者信息

Lee Jung Lim, Kim Youngji

机构信息

Department of Nursing, Daejeon University, Daejeon 34520, Republic of Korea.

Department of Nursing, College of Nursing and Health, Kongju National University, Gongju 32588, Republic of Korea.

出版信息

Healthcare (Basel). 2024 Jan 31;12(3):368. doi: 10.3390/healthcare12030368.

Abstract

There has been increasing interest in mobile healthcare for diabetes management. However, there remains limited evidence regarding the effectiveness of these mobile applications (apps). This scoping review aimed to evaluate the clinical effectiveness of mobile diabetes management apps. We used the following search terms: "mobile app", "mobile application", and "diabetes". We included only articles written in English and published between January 2016 and August 2021. We identified two, six, and four articles focused on type 1 diabetes, type 2 diabetes, and both diabetes types, respectively. Five, four, and three of these studies reported on the apps' functionality, usability, and both, respectively. Our findings indicated that diabetes mobile apps allowed for convenient user experience and improved blood sugar levels in patients with diabetes. Considering these findings, usability must be comprehensively evaluated by using definitions such as the ISO9241-11 usability definition or the mobile application rating scale (MARS) when developing diabetes-related apps. For the feasibility of diabetes mobile apps, we recommend that HbA1C and self-management be included as evaluation variables. Given the increasing importance of continuous management for patients with diabetes, interventions using mobile apps are bound to become effective tools for patient-led self-management.

摘要

人们对用于糖尿病管理的移动医疗保健的兴趣与日俱增。然而,关于这些移动应用程序(应用)有效性的证据仍然有限。本综述旨在评估移动糖尿病管理应用的临床有效性。我们使用了以下搜索词:“移动应用”、“移动程序”和“糖尿病”。我们仅纳入2016年1月至2021年8月期间发表的英文文章。我们分别确定了两篇、六篇和四篇关注1型糖尿病、2型糖尿病以及两种糖尿病类型的文章。其中五项、四项和三项研究分别报告了应用的功能、可用性以及两者。我们的研究结果表明,糖尿病移动应用为用户提供了便捷的体验,并改善了糖尿病患者的血糖水平。考虑到这些发现,在开发与糖尿病相关的应用时,必须使用ISO9241-11可用性定义或移动应用评分量表(MARS)等定义对可用性进行全面评估。对于糖尿病移动应用的可行性,我们建议将糖化血红蛋白(HbA1C)和自我管理纳入评估变量。鉴于对糖尿病患者进行持续管理的重要性日益增加,使用移动应用的干预措施必将成为患者主导的自我管理的有效工具。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/508e/10855494/113d52b9b883/healthcare-12-00368-g001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验